160 related articles for article (PubMed ID: 28002960)
1. Characterization of New Cationic N,N-Dimethyl[70]fulleropyrrolidinium Iodide Derivatives as Potent HIV-1 Maturation Inhibitors.
Castro E; Martinez ZS; Seong CS; Cabrera-Espinoza A; Ruiz M; Hernandez Garcia A; Valdez F; Llano M; Echegoyen L
J Med Chem; 2016 Dec; 59(24):10963-10973. PubMed ID: 28002960
[TBL] [Abstract][Full Text] [Related]
2. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
Martinez ZS; Castro E; Seong CS; Cerón MR; Echegoyen L; Llano M
Antimicrob Agents Chemother; 2016 Oct; 60(10):5731-41. PubMed ID: 27431232
[TBL] [Abstract][Full Text] [Related]
3. Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease.
Yasuno T; Ohe T; Kataoka H; Hashimoto K; Ishikawa Y; Furukawa K; Tateishi Y; Kobayashi T; Takahashi K; Nakamura S; Mashino T
Bioorg Med Chem Lett; 2021 Jan; 31():127675. PubMed ID: 33161121
[TBL] [Abstract][Full Text] [Related]
4. Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.
Ghimire D; Timilsina U; Srivastava TP; Gaur R
Sci Rep; 2017 Mar; 7():43711. PubMed ID: 28252110
[TBL] [Abstract][Full Text] [Related]
5. Fullerene Derivatives Prevent Packaging of Viral Genomic RNA into HIV-1 Particles by Binding Nucleocapsid Protein.
Křížová I; Dostálková A; Castro E; Prchal J; Hadravová R; Kaufman F; Hrabal R; Ruml T; Llano M; Echegoyen L; Rumlová M
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960720
[TBL] [Abstract][Full Text] [Related]
6. Novel pyridinium-type fullerene derivatives as multitargeting inhibitors of HIV-1 reverse transcriptase, HIV-1 protease, and HCV NS5B polymerase.
Kobayashi T; Yasuno T; Takahashi K; Nakamura S; Mashino T; Ohe T
Bioorg Med Chem Lett; 2021 Oct; 49():128267. PubMed ID: 34271071
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease.
Tyndall JD; Reid RC; Tyssen DP; Jardine DK; Todd B; Passmore M; March DR; Pattenden LK; Bergman DA; Alewood D; Hu SH; Alewood PF; Birch CJ; Martin JL; Fairlie DP
J Med Chem; 2000 Sep; 43(19):3495-504. PubMed ID: 11000004
[TBL] [Abstract][Full Text] [Related]
8. New anti-HIV derivatives: synthesis and antiviral evaluation.
De Michelis C; Rocheblave L; Priem G; Chermann JC; Kraus JL
Bioorg Med Chem; 2000 Jun; 8(6):1253-62. PubMed ID: 10896105
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands.
Zhu M; Du XN; Li YG; Zhang GN; Wang JX; Wang YC
Bioorg Med Chem Lett; 2019 Feb; 29(3):357-361. PubMed ID: 30580917
[TBL] [Abstract][Full Text] [Related]
10. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, properties and photodynamic inactivation of Escherichia coli by novel cationic fullerene C60 derivatives.
Spesia MB; Milanesio ME; Durantini EN
Eur J Med Chem; 2008 Apr; 43(4):853-61. PubMed ID: 17706838
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activity of new anti-HIV amprenavir bioisosteres.
Rocheblave L; Bihel F; De Michelis C; Priem G; Courcambeck J; Bonnet B; Chermann JC; Kraus JL
J Med Chem; 2002 Jul; 45(15):3321-4. PubMed ID: 12109915
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production.
Baraz L; Friedler A; Blumenzweig I; Nussinuv O; Chen N; Steinitz M; Gilon C; Kotler M
FEBS Lett; 1998 Dec; 441(3):419-26. PubMed ID: 9891983
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants.
Zhu M; Zhou H; Ma L; Dong B; Zhou J; Zhang G; Wang M; Wang J; Cen S; Wang Y
Eur J Med Chem; 2021 Aug; 220():113450. PubMed ID: 33906049
[TBL] [Abstract][Full Text] [Related]
15. Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs.
Su CT; Koh DW; Gan SK
Molecules; 2019 Sep; 24(18):. PubMed ID: 31489889
[TBL] [Abstract][Full Text] [Related]
16. Enhanced replication of R5 HIV-1 isolates in vitro by a small-molecule reagent targeting HIV-1 protease.
Wardle NJ; Hudson HR; Matthews RW; Nunn CM; Vella C; Bligh SW
ChemMedChem; 2013 May; 8(5):719-21. PubMed ID: 23509042
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-HIV activity of new C2 symmetric derivatives designed as HIV-1 protease inhibitors.
Peçanha EP; Figueiredo LJ; Brindeiro RM; Tanuri A; Calazans AR; Antunes OA
Farmaco; 2003 Feb; 58(2):149-57. PubMed ID: 12581781
[TBL] [Abstract][Full Text] [Related]
18. Advances in non-peptidomimetic HIV protease inhibitors.
Pang X; Liu Z; Zhai G
Curr Med Chem; 2014 Jun; 21(17):1997-2011. PubMed ID: 24533811
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dynamics Simulation Study of the HIV-1 Protease Inhibit ion Using Fullerene and New Fullerene Derivatives of Carbon Nanostructures.
Barzegar A; Naghizadeh E; Zakariazadeh M; Azamat J
Mini Rev Med Chem; 2017; 17(7):633-647. PubMed ID: 27292780
[TBL] [Abstract][Full Text] [Related]
20. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
